跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION
Authorized
STANDARD
MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION
dominion pharmacal
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d6974b27c37eb192
Company
dominion pharmacal
Type
Standard
Approval Details
Approval Id
d6974b27c37eb192
Drug Approval Canada Name
MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION
Product Name
MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION
Status
Cancelled Post Market
Status Date
2020-05-05
Original Market Date
2016-07-26
Din
02407523
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
56:28.12
Atc Original
A02BA02 RANITIDINE
Atc Name
a 02 ba 02
Aig Number
0115150002
Company Name
dominion pharmacal
Company Address
SUITE 100, 6111, Avenue Royalmount, Montreal, Quebec, Canada, H4P 2T4
Active Ingredients
RANITIDINE (RANITIDINE HYDROCHLORIDE)
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d6974b27c37eb192
Type
Standard
Back to Health Canada Approvals